Inj Triptorelin 11 point 25 mg, Inj Gemcitabine 1000 mg
Indian Army · Jalandhar City · Pharmaceuticals · open
Key facts
- Published: 04 Oct 2026
- Closing date: 26 Oct 2026
- Status: open
- Status as of: 04 Oct 2026 22:18 UTC
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
Description
Tender for supply of Triptorelin 11 point 25 mg and Gemcitabine 1000 mg with a total quantity of 60 units, issued by the Indian Army under the Department of Military Affairs, Ministry of Defence. The bid validity is 180 days from the end date, with technical evaluation, and includes conditions for MSE, MII preferences, and other statutory requirements.
Eligibility & requirements
- Experience required: 3 years
- Past performance: 80%
- Startup relaxation: Yes
- MSE relaxation: Yes
- Certifications: ISO 9001
- Documents required: Relevant contracts, Supply certificates, OEM authorization
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: Item wise evaluation
- Make in India (MII): Yes
- MSE preference: Yes
Line items (2)
- Triptorelin 11 point 25 mg — Qty: 30 vial
- Gemcitabine 1000 mg — Qty: 30 vial
1 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Hydraulic Cylinder and Related Components — Pharmaceuticals
- Procurement of Medicines and Sundries Items — Pharmaceuticals · West Bengal
- Veterinary Medicine Store Procurement — Pharmaceuticals · Nagaland